Search filters

List of works by Lucia Masarova

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

scientific article published on 04 September 2020

2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

scientific article published on 25 February 2020

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

scientific article published on 05 September 2018

Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome

scientific article

Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia

scientific article published on 19 July 2020

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

scientific article published on 22 February 2019

Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics

scientific article published on 24 September 2015

Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations

scientific article published on 29 October 2020

Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation

scientific article

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis

scientific article published on 20 June 2016

Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center

scientific article published on 05 November 2020

Emerging drugs for essential thrombocythemia

scientific article published on 14 May 2019

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

scientific article published on 21 October 2019

Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance

scientific article published on 8 March 2017

Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.

scientific article

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

scientific article published on 9 November 2017

Immunotherapy based approaches in myelofibrosis

scientific article published on 11 August 2017

Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009

scientific article published on 22 October 2012

Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study

scientific article published on 01 April 2020

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

scientific article published on 30 January 2020

Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis

scientific article published on 23 June 2016

Long-term results of frontline dasatinib in chronic myeloid leukemia

scientific article published on 30 January 2020

Mechanistic basis and efficacy of targeting β-catenin-TCF7L2-JMJD6-MYC axis to overcome resistance to BET inhibitors

scientific article published on 14 February 2020

Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics.

scientific article published on 15 November 2012

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

scientific article published on 09 October 2020

Novel treatment strategies for myeloproliferative neoplasms

scientific article published on 01 January 2019

Outcome of patients with IDH1/2-mutated post-myeloproliferative neoplasm AML in the era of IDH inhibitors

scientific article published on 01 November 2020

Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

scientific article published on 04 June 2020

Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms

scientific article published on 15 November 2017

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

scientific article

Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial

scientific article

Prognostic impact of RAS-pathway mutations in patients with myelofibrosis

scientific article published on 18 October 2019

Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era

scientific article published on 22 July 2020

Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report

scientific article published on 21 February 2020

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera - single center experience

scientific article

Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

scientific article published on 26 February 2020

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

scientific article

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells

scholarly article by Warren Fiskus et al published 15 January 2019 in Blood Cancer Journal

Survival following allogeneic transplant in patients with myelofibrosis

scientific article published on 01 May 2020

Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML

scientific article published on 21 December 2018

The Rationale for Immunotherapy in Myeloproliferative Neoplasms

scientific article published on 01 August 2019

The co-occurrence of driver mutations in chronic myeloproliferative neoplasms

scientific article published on 27 June 2018

The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis

scientific article published on 14 September 2020

The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis

scientific article published on 01 May 2019

Therapeutic Approach to Young Patients With Low-Risk Essential Thrombocythemia: Primum Non Nocere

scientific article published on 22 October 2018

Therapy-related myelofibrosis does not appear to exist

scientific article published on 26 May 2017

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

scientific article published on 01 August 2018

Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical Practice

scientific article published on 01 January 2018

Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias

scientific article published on 14 April 2020

Venetoclax with Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-related Mortality

scientific article published on 02 December 2020

Paulina is supported by:

About Paulina

Help